Nutriband logo

NutribandNASDAQ: NTRB

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

01 October 2021

Next earnings report:

13 December 2024

Last dividends:

N/A

Next dividends:

N/A
$68.69 M
-30%vs. 3y high
38%vs. sector
-vs. 3y high
-vs. sector
-27%vs. 3y high
84%vs. sector
-37%vs. 3y high
90%vs. sector

Price

regular market | Thu, 31 Oct 2024 20:00:00 GMT
$6.19+$0.02(+0.32%)

Dividend

No data over the past 3 years
$442.80 K-$1.71 M

Analysts recommendations

Institutional Ownership

NTRB Latest News

Nutriband Inc. Authorizes $1M Share Buyback Program
accesswire.com16 September 2024 Sentiment: POSITIVE

ORLANDO, FL / ACCESSWIRE / September 16, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced a share repurchase program to buy back up to $1,000,000 of its common stock. As of September 16, 2024, the Company had 11,106,185 shares of common stock outstanding.

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
accesswire.com04 September 2024 Sentiment: POSITIVE

ORLANDO, FL / ACCESSWIRE / September 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second quarter ended July 31, 2024. The Company reported a strong cash position at quarter end, reinforcing its ability to advance the development of its lead product, AVERSA™ Fentanyl, with an NDA submission targeted for the first half of 2025.

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
accesswire.com19 July 2024 Sentiment: POSITIVE

ORLANDO, FL / ACCESSWIRE / July 19, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased to invite investors to a webinar on July 25, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Nutriband Chairman and President Serguei Melnik and Chief Executive Officer Gareth Sheridan, who will share insight into the Company's current operations and upcoming milestones.

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
accesswire.com16 May 2024 Sentiment: POSITIVE

The Glinka family contributed $4.5 million to Nutriband during the Company's private placement in April 2024. Nutriband Inc. appointed Sergei Glinka to its board of directors, a well-respected business executive with extensive experience in leadership roles at prominent European companies.

What type of business is Nutriband?

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

What sector is Nutriband in?

Nutriband is in the Healthcare sector

What industry is Nutriband in?

Nutriband is in the Biotechnology industry

What country is Nutriband from?

Nutriband is headquartered in United States

When did Nutriband go public?

Nutriband initial public offering (IPO) was on 01 October 2021

What is Nutriband website?

https://www.nutriband.com

Is Nutriband in the S&P 500?

No, Nutriband is not included in the S&P 500 index

Is Nutriband in the NASDAQ 100?

No, Nutriband is not included in the NASDAQ 100 index

Is Nutriband in the Dow Jones?

No, Nutriband is not included in the Dow Jones index

When was Nutriband the previous earnings report?

No data

When does Nutriband earnings report?

The next expected earnings date for Nutriband is 13 December 2024